Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

1.

Optimal drug and behavior therapy for treatment-refractory schizophrenic patients.

Liberman RP, Van Putten T, Marshall BD Jr, Mintz J, Bowen L, Kuehnel TG, Aravagiri M, Marder SR.

Am J Psychiatry. 1994 May;151(5):756-9.

PMID:
8166320
[PubMed - indexed for MEDLINE]
2.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
3.

Optimal drug and behavior therapy for treatment-refractory institutionalized schizophrenics.

Kuehnel TG, Liberman RP, Marshall BD Jr, Bowen L.

New Dir Ment Health Serv. 1992 Spring;(53):67-78.

PMID:
1349727
[PubMed - indexed for MEDLINE]
4.

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.

Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB.

Am J Psychiatry. 1997 Jun;154(6):782-91.

PMID:
9167505
[PubMed - indexed for MEDLINE]
5.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia.

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
[PubMed - indexed for MEDLINE]
6.

Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.

Marder SR, Glynn SM, Wirshing WC, Wirshing DA, Ross D, Widmark C, Mintz J, Liberman RP, Blair KE.

Am J Psychiatry. 2003 Aug;160(8):1405-12.

PMID:
12900301
[PubMed - indexed for MEDLINE]
7.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
[PubMed - indexed for MEDLINE]
8.

Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.

de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.

Am J Psychiatry. 2003 Feb;160(2):303-9.

PMID:
12562577
[PubMed - indexed for MEDLINE]
9.

Impact of risperidone versus haloperidol on activities of daily living in the treatment of refractory schizophrenia.

Liberman RP, Gutkind D, Mintz J, Green M, Marshall BD Jr, Robertson MJ, Hayden J.

Compr Psychiatry. 2002 Nov-Dec;43(6):469-73.

PMID:
12439835
[PubMed - indexed for MEDLINE]
10.

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.

Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M.

Arch Gen Psychiatry. 2001 Oct;58(10):965-72.

PMID:
11576036
[PubMed - indexed for MEDLINE]
11.

Prediction of response to haloperidol dose reduction by Span of Apprehension measures for treatment-refractory schizophrenic patients.

Green MF, Mintz J, Bowen L, Marshall BD Jr, Kuehnel TG, Hayden JL, Liberman RP.

Am J Psychiatry. 1993 Sep;150(9):1415-6.

PMID:
8352355
[PubMed - indexed for MEDLINE]
12.

[Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].

Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M.

Encephale. 1995 Nov-Dec;21(6):417-24. French.

PMID:
8674466
[PubMed - indexed for MEDLINE]
13.

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.

Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P.

Arch Gen Psychiatry. 2002 May;59(5):441-8.

PMID:
11982448
[PubMed - indexed for MEDLINE]
14.

Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.

Müller MJ, Wetzel H, Eich FX, Rein W, Puech A, Benkert O; Amisulpride Study Group.

J Clin Psychopharmacol. 2002 Dec;22(6):554-60.

PMID:
12454554
[PubMed - indexed for MEDLINE]
15.

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

Kinon BJ, Basson BR, Gilmore JA, Tollefson GD.

J Clin Psychiatry. 2001 Feb;62(2):92-100.

PMID:
11247108
[PubMed - indexed for MEDLINE]
16.

Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents.

Glick ID, Lemmens P, Vester-Blokland E.

Int Clin Psychopharmacol. 2001 Sep;16(5):265-74.

PMID:
11552769
[PubMed - indexed for MEDLINE]
17.

Risperidone in treatment-refractory schizophrenia.

Wirshing DA, Marshall BD Jr, Green MF, Mintz J, Marder SR, Wirshing WC.

Am J Psychiatry. 1999 Sep;156(9):1374-9.

PMID:
10484947
[PubMed - indexed for MEDLINE]
18.

SPECT studies of D2 occupancy in low-dose haloperidol treatment.

Hirschowitz J, Hitzemann R, Vallabhajosula S.

Am J Psychiatry. 1997 May;154(5):715-6. No abstract available.

PMID:
9137141
[PubMed - indexed for MEDLINE]
19.

Haloperidol plasma levels and dose optimization.

Coryell W, Miller DD, Perry PJ.

Am J Psychiatry. 1998 Jan;155(1):48-53.

PMID:
9433338
[PubMed - indexed for MEDLINE]
20.

A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia.

Kane JM, Davis JM, Schooler N, Marder S, Casey D, Brauzer B, Mintz J, Conley R.

Am J Psychiatry. 2002 Apr;159(4):554-60.

PMID:
11925292
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk